Truxima 100 mg

Truxima 100 mg is a rituximab solution for intravenous use, designed for targeted therapy. This medication is commonly used in the management of certain autoimmune disorders and cancers.

Truxima 100 mg is primarily used in the treatment of non-Hodgkin's lymphoma and chronic lymphocytic leukemia. It may also be prescribed for rheumatoid arthritis in combination with other medications. Rituximab is a monoclonal antibody that targets specific cells in the body, helping to modulate the immune system.

Common effects of Truxima 100 mg may include infusion-related reactions such as fever, chills, and fatigue. Some individuals may experience a temporary decrease in blood cell counts. Always consult a healthcare provider for personalized advice.

Truxima 100 mg should be administered under medical supervision. It is important to inform your healthcare provider about any allergies or existing medical conditions. Regular monitoring may be required during treatment.

Truxima 100 mg may interact with other medications, including those that affect the immune system. It is advisable to avoid alcohol and consult a healthcare provider before taking any new medications.